Skip to main content
Log in

Effect of food on the absorption and pharmacokinetics of prednisolone from enteric-coated tablets

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Prednisolone absorption and bioavailability of 10 mg enteric-coated (EC) and plain (uncoated) tablets were investigated after fasting and heavy meals (EC only) consumed to satiety in normal healthy volunteers. The same volunteers had also received 16 mg of prednisolone intravenously.

In fasted subjects, the absolute bioavailability fraction, as normalised for intravenous doses, of prednisolone from plain tablets was 1.055 and from EC tablets was 0.996. The peak concentrations after plain and EC tablets were 309 and 249 ng/ml attained at 0.98 and 5.14 h, respectively. The means plasma elimination half-lives following the plain, EC tablets and intravenous administration in fasting conditions were 3.73, 3.89 and 3.78 h, respectively.

Food interfered with both the absorption and the pharmacokinetics of prednisolone after EC tablets resulting in variability in its plasma levels. In some cases absorption of prednisolone was delayed for 12 h and remained at a measurable level for 24 h. In other cases, a normal absorption pattern was observed.

This inter- and intrasubject variability of the effect of food appears to be related to its quantity, constituents and also the subjects physiological characteristics. It is concluded that enteric-coated prednisolone tablets should be administered at least 2 h between meals. However, for more predictable corticosteroid absorption (perhaps thus avoiding the therapeutic failure), plain prednisolone tablets are preferable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Schneller GH (1969) Hazard of therapeutic nonequivalency of drug products. J Am Pharm Ass 9: 455–459

    Google Scholar 

  2. Healey LA (1973) Generic equivalents. Arthritis Rheum 16: 775

    Google Scholar 

  3. Levy G, Hall NA, Nelson E (1964) Studies on inactive prednisone tablets USP XVI. Am J Hosp Pharm 21: 402

    Google Scholar 

  4. Campagna FA, Cureton G, Mirigian RA, Nelson E (1963) Inactive prednisone tablets USP. XVI. J Pharm Sci 52: 605–606

    Google Scholar 

  5. Al-Habet S, Kinsella HC, Rogers HJ, Trounce JR (1980) Malabsorption of prednisolone from enteric-coated tablets after ileostomy. Br Med J 281: 843–844

    Google Scholar 

  6. Olivesi A (1985) Non-absorption of enteric-coated prednisolone. Therapie 40: 5–7

    Google Scholar 

  7. Fernando ON, Moorhead J (1979) Absorption of enteric-coated prednisolone. Br Med 1: 1795–1796

    Google Scholar 

  8. Henderson RG, Wheatley T, English J, Chakraborty J, Marks V (1979) Variation in plasma prednisolone concentrations in renal transplant recipients given enteric-coated prednisolone. Br Med J 1: 1534–1536

    Google Scholar 

  9. Mant TGK (1979) Investigation of a case of prednisolone malabsorption. Postgrad Med J 55: 421–422

    Google Scholar 

  10. Hulme B, James VHT, Rault R (1975) Absorption of enteric and non-enteric coated prednisolone tablets. Br J Clin Pharmacol 2: 317–320

    Google Scholar 

  11. Lee DAH, Taylor GM, Walker JG, James VHT (1979) The effect of food and tablet formulation on plasma prednisolone levels following administration of enteric-coated tablets. Br J Clin Pharmacol 7: 523–528

    Google Scholar 

  12. Morrison PJ, Bradbrook ID, Rogers HJ (1977) Plasma prednisolone levels from enteric and non-enteric-coated tablets estimated by an original technique. Br J Clin Pharmacol 4: 597–603

    Google Scholar 

  13. Wilson CG, May CS, Paterson JW (1977) Plasma prednisolone levels after administration in plain and enteric-coated tablets. Br J Clin Pharmacol 4: 703–704

    Google Scholar 

  14. Leclercq R, Copinschi G (1974) Pattern of plasma levels of prednisolone after oral administration in man. J Pharmacokinet Biopharm 2: 175–187

    Google Scholar 

  15. Tembo AV, Sakmar E, Hallmark MR, Weidler DJ, Wagner JG (1976) Effect of food on the bioavailability of prednisone. J Clin Pharmacol 16: 620–624

    Google Scholar 

  16. Uribe M, Schalm SW, Summerskill WHJ, Go VLW (1976) Effect of liquid diet on serum protein binding and prednisolone concentrations after oral prednisone. Gastroenterology 71: 362–364

    Google Scholar 

  17. Al-Habet S, Rogers HJ (1980) Pharmacokinetics of intravenous and oral prednisolone. Br J Clin Pharmacol 10: 503–508

    Google Scholar 

  18. Al-Habet SMH, McAllister WAC, Collins JV, Rogers HJ (1981) Comparison of radioimmunoassay and thin layer chromatographic assay methods for estimation of plasma prednisolone concentrations. J Pharmacol Methods 6: 137–142

    Google Scholar 

  19. Al-Habet SMH, Rogers HJ (1989) Two chromatographic methods for the determination of corticosteroids in human biological fluids: pharmacokinetic applications. J Pharm Sci 78: 660–666

    Google Scholar 

  20. Al-Habet SMH, Rogers HJ (1989) Methylprednisolone pharmacokinetics after intravenous and oral administration. Br J Clin Pharmacol 27: 285–290

    Google Scholar 

  21. Melander A, Laka D, McLean A (1988) Influence of food on the presystemic metabolism of drugs. Pharmacol Ther 38: 253–267

    Google Scholar 

  22. Yang CS, Yoo JH (1988) Dietary effects on drug metabolism by the mixed-function oxidase system. Pharmacol Ther 38: 53–72

    Google Scholar 

  23. Welling PG (1986) Pharmacokinetic processes and mathematics, chapters 5 and 6. Pub ACS Monograph 185, American Chemical Society, Washington DC, pp 45–76

    Google Scholar 

  24. Johansson O, Lindberg T, Melander A, Wåhlin-Boll E (1985) Different effects of different nutrients on theophylline absorption in man. Drug Nutr Interact 3: 205–211

    Google Scholar 

  25. Hathcock TN (1985) Metabolic mechanism of drug-nutrient interactions. Fed Proc 44: 124–129

    Google Scholar 

  26. Al-Habet SM, Rogers HJ (1985) Prednisolone elimination in human saliva. Int J Clin Pharmacol Ther Toxicol 23: 485–487

    Google Scholar 

  27. Al-Habet SMH, Rogers HJ (1989) Urinary excretion of prednisolone following intravenous administration in human. J Clin Pharmacol 29: (October)

Download references

Author information

Authors and Affiliations

Authors

Additional information

Part of this study was presented at the joint annual meeting of the American College of Clinical Pharmacology (ACCP) and the American Association of pharmaceutical Scientists (AAPS), Orlando, Florida, (J Clin Pharmacol 28 (1988): 923–924)

Deceased

Rights and permissions

Reprints and permissions

About this article

Cite this article

Al-Habet, S.M.H., Rogers, H.J. Effect of food on the absorption and pharmacokinetics of prednisolone from enteric-coated tablets. Eur J Clin Pharmacol 37, 423–426 (1989). https://doi.org/10.1007/BF00558515

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00558515

Key words

Navigation